25 Anniversary Spotlight

About Our 25 for 25

Friends of Cancer Research is proud to present 25 scientific and advocacy leaders who, through their work and partnership with Friends, have been instrumental over the course of our 25 years in making significant advancements for patients.

These individuals’ dedication to patients is unsurpassed, and they have helped shape our work while catalyzing innovation and improvements in healthcare through their work. It is thanks to these leaders and their integral role in Friends that we have achieved the level of success for patients that we have to date.

Stay tuned every other week as we unveil a new leader of the health field that we would like to thank for helping Friends become the small, but mighty organization we are today.

New!

Roy Herbst

Chief of Medical Oncology, Yale Cancer Center

Dr. Herbst is one of the foremost leaders in lung cancer treatment and research. He is an original architect and principal investigator of Lung-MAP, a first-of-its-kind clinical trial that originated from our Annual Meeting and has reshaped how clinical trials are conducted. Bio

Chief of Medical Oncology, Yale Cancer Center

Dr. Herbst is one of the foremost leaders in lung cancer treatment and research. He is an original architect and principal investigator of Lung-MAP, a first-of-its-kind clinical trial that originated from our Annual Meeting and has reshaped how clinical trials are conducted. Bio

New!

Richard Pazdur

Director, Oncology Center of Excellence, FDA

A visionary leader in oncology, Dr. Pazdur has dedicated his life and career to improving the lives of cancer patients. Throughout his storied career at FDA, he has led continuous process improvements, shepherded a new era of science, and transformed the Agency’s approach to oncology. He has been at the epicenter of Friends’ most impactful work. Bio

Director, Oncology Center of Excellence, FDA

A visionary leader in oncology, Dr. Pazdur has dedicated his life and career to improving the lives of cancer patients. Throughout his storied career at FDA, he has led continuous process improvements, shepherded a new era of science, and transformed the Agency’s approach to oncology. He has been at the epicenter of Friends’ most impactful work. Bio

Marian Johnson-Thompson

Professor Emerita of Biology, University of the District of Columbia (UDC) & Adjunct Professor, Maternal and Child Health, School of Global Public Health, UNC-Chapel Hill

Dr. Johnson-Thompson is a virologist with decades of experience in clinical trial research. She is also a passionate patient advocate and has been a steadfast partner with Friends over the years on several educational initiatives including ProgressForPatients.org and Project TEACH. Bio

Professor Emerita of Biology, University of the District of Columbia (UDC) & Adjunct Professor, Maternal and Child Health, School of Global Public Health, UNC-Chapel Hill

Dr. Johnson-Thompson is a virologist with decades of experience in clinical trial research. She is also a passionate patient advocate and has been a steadfast partner with Friends over the years on several educational initiatives including ProgressForPatients.org and Project TEACH. Bio

The Honorable Michael Bennet

U.S. Senator for the State of Colorado

Sen. Michael Bennet (D-CO) has made a political career of creating impactful policy for the benefit of patients. He was one of the first to standup and help Friends champion the breakthrough therapy designation, which was passed into law in 2012. Bio

U.S. Senator for the State of Colorado

Sen. Michael Bennet (D-CO) has made a political career of creating impactful policy for the benefit of patients. He was one of the first to standup and help Friends champion the breakthrough therapy designation, which was passed into law in 2012. Bio

Richard Klausner

Founder and Executive Chairman, Lyell Immunopharma, Inc.

A true innovator and renowned scientist. During his time as NCI Director, Dr. Klausner worked tirelessly to lead NCI to become the collaborative and forward-looking institution it is today. He was also a driving force behind the creation of Friends. Bio

Founder and Executive Chairman, Lyell Immunopharma, Inc.

A true innovator and renowned scientist. During his time as NCI Director, Dr. Klausner worked tirelessly to lead NCI to become the collaborative and forward-looking institution it is today. He was also a driving force behind the creation of Friends. Bio

Ed Kim

Physician-in-Chief, City of Hope Orange County

Ed Kim, renowned lung cancer specialist, has led our work expanding eligibility criteria to make clinical trials more representative and accessible to more patients. Each project working group’s latest publications were released in early 2021. Bio

Physician-in-Chief, City of Hope Orange County

Ed Kim, renowned lung cancer specialist, has led our work expanding eligibility criteria to make clinical trials more representative and accessible to more patients. Each project working group’s latest publications were released in early 2021. Bio

Debbie Dingell

Congresswoman

A founding member of the Friends board, Rep. Debbie Dingell (D-MI) is a lifelong advocate to ensure patients have access to quality healthcare.  Believing in our mission, she helped lay the foundation for the organization. Bio

Congresswoman

A founding member of the Friends board, Rep. Debbie Dingell (D-MI) is a lifelong advocate to ensure patients have access to quality healthcare.  Believing in our mission, she helped lay the foundation for the organization. Bio

Mark McClellan

Director of the Duke-Margolis Center for Health Policy at Duke University

A foremost expert in healthcare through public service and innovative polices, our unique, collaborative model of constructing policy papers to actionable solutions was created with Mark in what has led to our annual meetings. Bio

Director of the Duke-Margolis Center for Health Policy at Duke University

A foremost expert in healthcare through public service and innovative polices, our unique, collaborative model of constructing policy papers to actionable solutions was created with Mark in what has led to our annual meetings. Bio

Coming soon...

New!

Roy Herbst

Chief of Medical Oncology, Yale Cancer Center

Dr. Herbst is one of the foremost leaders in lung cancer treatment and research. He is an original architect and principal investigator of Lung-MAP, a first-of-its-kind clinical trial that originated from our Annual Meeting and has reshaped how clinical trials are conducted. Bio

Chief of Medical Oncology, Yale Cancer Center

Dr. Herbst is one of the foremost leaders in lung cancer treatment and research. He is an original architect and principal investigator of Lung-MAP, a first-of-its-kind clinical trial that originated from our Annual Meeting and has reshaped how clinical trials are conducted. Bio

New!

Richard Pazdur

Director, Oncology Center of Excellence, FDA

A visionary leader in oncology, Dr. Pazdur has dedicated his life and career to improving the lives of cancer patients. Throughout his storied career at FDA, he has led continuous process improvements, shepherded a new era of science, and transformed the Agency’s approach to oncology. He has been at the epicenter of Friends’ most impactful work. Bio

Director, Oncology Center of Excellence, FDA

A visionary leader in oncology, Dr. Pazdur has dedicated his life and career to improving the lives of cancer patients. Throughout his storied career at FDA, he has led continuous process improvements, shepherded a new era of science, and transformed the Agency’s approach to oncology. He has been at the epicenter of Friends’ most impactful work. Bio

Marian Johnson-Thompson

Professor Emerita of Biology, University of the District of Columbia (UDC) & Adjunct Professor, Maternal and Child Health, School of Global Public Health, UNC-Chapel Hill

Dr. Johnson-Thompson is a virologist with decades of experience in clinical trial research. She is also a passionate patient advocate and has been a steadfast partner with Friends over the years on several educational initiatives including ProgressForPatients.org and Project TEACH. Bio

Professor Emerita of Biology, University of the District of Columbia (UDC) & Adjunct Professor, Maternal and Child Health, School of Global Public Health, UNC-Chapel Hill

Dr. Johnson-Thompson is a virologist with decades of experience in clinical trial research. She is also a passionate patient advocate and has been a steadfast partner with Friends over the years on several educational initiatives including ProgressForPatients.org and Project TEACH. Bio

The Honorable Michael Bennet

U.S. Senator for the State of Colorado

Sen. Michael Bennet (D-CO) has made a political career of creating impactful policy for the benefit of patients. He was one of the first to standup and help Friends champion the breakthrough therapy designation, which was passed into law in 2012. Bio

U.S. Senator for the State of Colorado

Sen. Michael Bennet (D-CO) has made a political career of creating impactful policy for the benefit of patients. He was one of the first to standup and help Friends champion the breakthrough therapy designation, which was passed into law in 2012. Bio

Richard Klausner

Founder and Executive Chairman, Lyell Immunopharma, Inc.

A true innovator and renowned scientist. During his time as NCI Director, Dr. Klausner worked tirelessly to lead NCI to become the collaborative and forward-looking institution it is today. He was also a driving force behind the creation of Friends. Bio

Founder and Executive Chairman, Lyell Immunopharma, Inc.

A true innovator and renowned scientist. During his time as NCI Director, Dr. Klausner worked tirelessly to lead NCI to become the collaborative and forward-looking institution it is today. He was also a driving force behind the creation of Friends. Bio

Ed Kim

Physician-in-Chief, City of Hope Orange County

Ed Kim, renowned lung cancer specialist, has led our work expanding eligibility criteria to make clinical trials more representative and accessible to more patients. Each project working group’s latest publications were released in early 2021. Bio

Physician-in-Chief, City of Hope Orange County

Ed Kim, renowned lung cancer specialist, has led our work expanding eligibility criteria to make clinical trials more representative and accessible to more patients. Each project working group’s latest publications were released in early 2021. Bio

Debbie Dingell

Congresswoman

A founding member of the Friends board, Rep. Debbie Dingell (D-MI) is a lifelong advocate to ensure patients have access to quality healthcare.  Believing in our mission, she helped lay the foundation for the organization. Bio

Congresswoman

A founding member of the Friends board, Rep. Debbie Dingell (D-MI) is a lifelong advocate to ensure patients have access to quality healthcare.  Believing in our mission, she helped lay the foundation for the organization. Bio

Mark McClellan

Director of the Duke-Margolis Center for Health Policy at Duke University

A foremost expert in healthcare through public service and innovative polices, our unique, collaborative model of constructing policy papers to actionable solutions was created with Mark in what has led to our annual meetings. Bio

Director of the Duke-Margolis Center for Health Policy at Duke University

A foremost expert in healthcare through public service and innovative polices, our unique, collaborative model of constructing policy papers to actionable solutions was created with Mark in what has led to our annual meetings. Bio

Coming soon...